Tijdschr Gerontol Geriatr. 2009 Feb;40(1):29-33.

[Cognitive impairment and parkinsonism due to use of sodium valproate].

[Article in Dutch]

Schreur L, Middeljans-Tijssen CW, Hengstman GJ, Olde Rikkert MG.

Source

Klinisch geriater in opleiding, Afdeling geriatrie, Universitair Medisch Centrum St Radboud, Nijmegen.

Abstract

Two patients presented with progressive cognitive impairment and parkinsonism related symptoms while being treated with sodium valproate. Both patients suffered from progressive cognitive decline and mobility disorders with an insidious onset over a period of months to years. After discontinuation of sodium valproate both debilitating symptoms resolved nearly completely. There is a growing prevalence and incidence of epilepsy above the age of 60 and a great number of these patients are on sodium valproate treatment. All clinicians treating elderly patients should be aware of the fact that this treatment can cause reversible cognitive decline and parkinsonism probably due to impairment of mitochondrial complex I function. Discontinuation of sodium valproate is strongly recommended in all patients with development of cognitive impairment or parkinsonism or both during sodium valproate treatment.

PMID:: 19326700; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

EBSCO

Molecular Biology Databases

VALPROIC ACID - HSDB

Supplemental Content

Save items

Related citations in PubMed

The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. [Epilepsia. 2006]
The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
Ristić AJ, Vojvodić N, Janković S, Sindelić A, Sokić D. Epilepsia. 2006 Dec; 47(12):2183-5.
Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. [Neurology. 2004]
Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate.
Easterford K, Clough P, Kellett M, Fallon K, Duncan S. Neurology. 2004 Apr 27; 62(8):1435-7.
Reversible parkinsonism and cognitive impairment with chronic valproate use. [Neurology. 1996]
Reversible parkinsonism and cognitive impairment with chronic valproate use.
Armon C, Shin C, Miller P, Carwile S, Brown E, Edinger JD, Paul RG. Neurology. 1996 Sep; 47(3):626-35.
Review [Valproate induced parkinsonism]. [No To Shinkei. 1998]
Review [Valproate induced parkinsonism].
Park-Matsumoto YC, Tazawa T. No To Shinkei. 1998 Jan; 50(1):81-4.
Review Valproate preparations for agitation in dementia. [Cochrane Database Syst Rev. 2009]
Review Valproate preparations for agitation in dementia.
Lonergan E, Luxenberg J. Cochrane Database Syst Rev. 2009 Jul 8; (3):CD003945. Epub 2009 Jul 8.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[Cognitive impairment and parkinsonism due to use of sodium valproate].
[Cognitive impairment and parkinsonism due to use of sodium valproate].
Tijdschr Gerontol Geriatr. 2009 Feb ;40(1):29-33.

PubMed
Human papillomavirus and head and neck cancer: a growing concern.
Human papillomavirus and head and neck cancer: a growing concern.
J S C Med Assoc. 2008 Dec ;104(8):247-51.

PubMed
Protective effects of angiotensin AT1 receptor blockade in malignant hypertensio...
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Eur J Pharmacol. 2009 Apr 1 ;607(1-3):126-34.

PubMed
Measures of executive function and depression identify patients at risk for post...
Measures of executive function and depression identify patients at risk for postoperative delirium.
Anesthesiology. 2009 Apr ;110(4):788-95.

PubMed
Phthalimide neovascular factor 1 (PNF1) modulates MT1-MMP activity in human micr...
Phthalimide neovascular factor 1 (PNF1) modulates MT1-MMP activity in human microvascular endothelial cells.
Biotechnol Bioeng. 2009 Jul 1 ;103(4):796-807.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: